Finance

Lists
Why is PHGN down 2.83%?
Dive Deeper
PHGN:FRA
Pharming Group NV
€0.83
-2.83%
(-0.024) 1D
Oct 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHGN...
Open
€0.83
High
€0.83
Low
€0.83
Mkt. cap
577.81M
Avg. vol.
1.13K
Volume
0.00
P/E ratio
51.56
52-wk high
€1.76
52-wk low
€0.83
EPS
€0.02
No. of employees
407
Open
€0.83
High
€0.83
Low
€0.83
Mkt. cap
577.81M
Avg. vol.
1.13K
Volume
0.00
P/E ratio
51.56
52-wk high
€1.76
52-wk low
€0.83
EPS
€0.02
No. of employees
407
News stories
From web sources and news partners
About Pharming Group NV
CEO-
Employees407
Founded1988
Headquarters-
SectorBiotechnology
Websitepharming.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
97.29M
106.53M
72.45M
90.21M
Cost of goods sold
7.07M
21.13M
6.64M
14.54M
Cost of revenue
7.07M
21.13M
6.64M
14.54M
Research and development expenses
21.28M
32.05M
25.56M
32.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.08M
50.67M
45.53M
43.52M
Operating expense
64.29M
82.37M
70.71M
74.36M
Total operating expenses
71.36M
103.50M
77.36M
88.90M
Operating income
25.92M
3.03M
-4.91M
1.31M
Other non operating income
1.88M
403.00K
-
-32.00K
EBT including unusual items
12.76M
4.80M
-4.75M
3.04M
EBT excluding unusual items
22.86M
1.61M
-4.75M
3.04M
Income tax expense
5.21M
-528.00K
459.00K
1.40M
Effective tax rate
40.83%
-11.00%
-9.65%
46.12%
Other operating expenses
-71.00K
-348.00K
-377.00K
-1.42M
Net income
7.55M
5.33M
-5.21M
1.64M
Net profit margin
7.76%
5.00%
-7.20%
1.82%
Earnings per share
0.01
0.01
-0.07
0.00
Interest and investment income
-
4.50M
3.24M
-
Interest expense
-9.21M
-
-2.70M
-4.10M
Net interest expenses
-9.21M
4.50M
542.00K
-4.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
30.12M
6.24M
-1.80M
2.67M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps